Biogen Inc
Drug Manufacturers - General
Healthcare
BIIB
146 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
110.31
52 week high
236.80
high
121.08
52 week low
114.05
low
110.04
growth
-46.43 %
previous Close
114.05
P/E ratio
30
market cap
21.77 B
div yield
0
usd
Sep 2024
qoq
revenue
2.47 B
4.79 %
net incoming
389 M
-33.43 %
eps
4.08 %
-22.73 %
eps surprise
7.65 %
net profit margin
15.76 %
-9.00 %
operating incoming
496 M
-23.91 %
net change in cash
-209.70 M
-125.13 %
cash on hand
1.70 B
-10.99 %
cost of revenue
639 M
-9.38 %
top top